Almotriptan Malate Tablet, Film Coated
Product Images NDC 0378-5245

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Almotriptan Malate (NDC 0378-5245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In Adults (Image 01)

A line graph showing probability versus hours post dose for Almotriptan tablets. It compares placebo, Almotriptan 6.25 mg, and Almotriptan 12.5 mg over 2 hours, illustrating increasing probability with higher doses and time after administration.*

FDA Label Image

Figure 2. Estimated Probability Of Adult Patients Taking Escape Medication Or A Second Dose Of Study Medication Over The 24 Hours Following The Initial Dose Of Study Treatment (Image 02)

A line graph depicting the probability of an effect over 24 hours post dose for Almotriptan tablets in 6.25 mg and 12.5 mg strengths compared to placebo. The x-axis represents hours post dose (0 to 24), and the y-axis represents probability (0 to 1). Almotriptan 12.5 mg shows the highest probability curve, followed by 6.25 mg and placebo.*

FDA Label Image

Figure 3. Estimated Probability Of Achieving An Initial Headache Response (mild Or No Pain) In 2 Hours In The Adolescent Study (Image 03)

A line graph depicting the estimated probability of response over hours post dose for Almotriptan 6.25 mg, Almotriptan 12.5 mg, and placebo. The x-axis shows hours post dose from 0 to 2, and the y-axis shows estimated probability of response from 0 to 1. Almotriptan 12.5 mg and 6.25 mg show higher response probabilities compared to placebo over time.*

FDA Label Image

Almotriptan Malate Structural Formula (Image 04)

Chemical structure of Almotriptan Malate as shown in the image, depicting its molecular configuration with functional groups and molecular bonds.*

FDA Label Image

Almotriptan Tablets, Usp 6.25 mg Carton Label (Image 05)

Packaging label for Almotriptan tablets USP 6.25 mg by Mylan Pharmaceuticals Inc. The label indicates film-coated oral tablets, available as 6 unit-dose tablets (1 card of 6 tablets). It includes the NDC 0378-5245-85, and shows tablet imprints 'AL1'. Storage instructions and manufacturer details (Mylan Pharmaceuticals Inc., Morgantown, WV) are also visible.*

FDA Label Image

Almotriptan Tablets, Usp 12.5 mg Carton Label (Image 06)

Packaging label for Almotriptan Tablets, USP 12.5 mg film-coated oral tablets by Mylan Pharmaceuticals Inc. The label indicates 12 unit-dose tablets (2 cards x 6 tablets) per package. The label shows the drug name, dosage strength, tablet imprint 'AL2', NDC 0378-5246-85, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.